The growing popularity of weight-loss medications such as Ozempic and Wegovy has led to a sharp increase in calls to poison control centers, according to a new study. Health experts say most of the reported cases are linked to accidental dosing errors rather than intentional misuse, highlighting the need for better patient education.
The findings come as the demand for GLP-1 medications continues to rise worldwide, with millions of people using them to manage type 2 diabetes and obesity.
Increase in Poison Control Reports
Researchers found that poison control centers have received a significant increase in reports involving semaglutide the active ingredient in Ozempic and Wegovy—in recent years.
Many incidents involved patients accidentally taking the wrong dose, using the medication incorrectly, or confusing weekly injections with daily medicines. While most cases resulted in mild to moderate symptoms, some individuals required hospital treatment.
Medical professionals say the trend reflects the rapid growth in prescriptions rather than evidence that the medicines themselves are unsafe when used correctly.
Common Symptoms Reported
According to health experts, taking too much semaglutide can cause:
- Severe nausea
- Repeated vomiting
- Diarrhea
- Abdominal pain
- Dizziness
- Dehydration
- Low blood sugar, especially in people using insulin or certain diabetes medications
Doctors advise anyone experiencing severe or persistent symptoms after taking the medication to seek immediate medical attention.
Why Dosing Mistakes Happen
Experts say several factors contribute to dosing errors, including:
- Misunderstanding weekly injection schedules.
- Using compounded or unapproved versions of the medication.
- Incorrectly measuring doses from multi-dose pens.
- Failing to follow healthcare providers’ instructions.
Patients who are new to injectable medicines may also struggle with proper administration if they do not receive adequate training.
Demand Continues to Grow
Ozempic and Wegovy have become some of the world’s most talked-about medications because of their effectiveness in helping people lose weight and improve blood sugar control.
Their popularity has also contributed to supply shortages in some countries, leading some consumers to purchase medications from unauthorized online sources or use compounded products that may carry additional risks.
Health authorities continue to warn the public against buying prescription medicines from unverified sellers.
Health Experts Urge Safe Use
Medical professionals stress that these medications remain safe and effective when prescribed by qualified healthcare providers and used according to instructions.
Patients are encouraged to:
- Follow the prescribed dosage carefully.
- Never increase the dose without medical advice.
- Store the medication properly.
- Keep medicines out of the reach of children.
- Contact a healthcare provider if they miss a dose or are unsure how to administer the injection.
Experts also recommend regular follow-up appointments to monitor progress and manage any side effects.
Growing Need for Patient Education
Researchers say the increase in poison control calls highlights the importance of educating patients before they begin treatment.
Healthcare providers are being encouraged to spend more time demonstrating how to use injectable weight-loss medicines correctly and explaining possible side effects.
As demand for GLP-1 medications continues to rise, experts believe better patient education will help reduce medication errors while ensuring people receive the full benefits of treatment.
